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Background: Anemia and renal insufficiency (RI) correlate with adverse outcomes in heart failure (HF). Data relating HF stage with prevalence and 
prognostic impact of these comorbidities are scarce. Based on prospectively collected Competence Net Heart Failure (CNHF) data we systematically 
addressed this issue.
Methods: Patients were gleaned from 4 CNHF cohorts, if they had complete standardized data sets including echo/Doppler obtained at baseline 
and a follow-up of at least 18 months. 3260 patients were allocated to ACC/AHA stages A (n=255), B (n=1311), C1 (NYHA I+II; n=1080), C2+D 
(NYHA III+IV, n=614). Anemia was defined as hemoglobin <13/12 g/dl in men/women (WHO criteria), and RI as a glomerular filtration rate <60 ml/
min/1.73m2.
Results: Average patient age in A/B/C1/C2+D was 64/67/65/68 yrs (P trend <0.001); 52/53/37/36% were female. Mean hemoglobin and GFR 
decreased with increasing HF severity (14.2±1.3/14.0±1.2/14.0±1.8/13.4±2 g/dl, P <0.001, and 76±18/74±18/74±24/64±26, P<0.001), while 
prevalence of anemia and RI increased (5/8/18/31%, P<0.001, and 19/21/27/48%, P<0.001). In Cox Regression adjusted for age, sex, ejection 
fraction, NYHA-class coincidence of anemia und RI was incrementally associated with mortality both in asymptomatic (stage B) and symptomatic 
patients (stage C+D).
Conclusions: Prevalence of both, anemia and RI is significant already in stages A/B and increases with HF severity. Impact on prognosis is 
cumulative and equally adverse in early and advanced HF stages.
